BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hoenigl M. Invasive Fungal Disease complicating COVID-19: when it rains it pours. Clin Infect Dis 2020:ciaa1342. [PMID: 32887998 DOI: 10.1093/cid/ciaa1342] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Dwivedi MK, Dwivedi A. Awareness Toward Mucormycosis Attack for COVID Patients. Microbiol Insights 2021;14:11786361211053003. [PMID: 34866911 DOI: 10.1177/11786361211053003] [Reference Citation Analysis]
2 Ewald J, Rivieccio F, Radosa L, Schuster S, Brakhage AA, Kaleta C. Dynamic optimization reveals alveolar epithelial cells as key mediators of host defense in invasive aspergillosis. PLoS Comput Biol 2021;17:e1009645. [PMID: 34898608 DOI: 10.1371/journal.pcbi.1009645] [Reference Citation Analysis]
3 Czyrski A, Resztak M, Świderski P, Brylak J, Główka FK. The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles. Pharmaceutics 2021;13:1961. [PMID: 34834376 DOI: 10.3390/pharmaceutics13111961] [Reference Citation Analysis]
4 Riad A, Shabaan AA, Issa J, Ibrahim S, Amer H, Mansy Y, Kassem I, Kassem AB, Howaldt HP, Klugar M, Attia S. COVID-19-Associated Mucormycosis (CAM): Case-Series and Global Analysis of Mortality Risk Factors. J Fungi (Basel) 2021;7:837. [PMID: 34682258 DOI: 10.3390/jof7100837] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
5 Banfalvi G. Janus-Faced Molecules against Plant Pathogenic Fungi. Int J Mol Sci 2021;22:12323. [PMID: 34830204 DOI: 10.3390/ijms222212323] [Reference Citation Analysis]
6 Costantini C, van de Veerdonk FL, Romani L. Covid-19-Associated Pulmonary Aspergillosis: The Other Side of the Coin. Vaccines (Basel) 2020;8:E713. [PMID: 33271780 DOI: 10.3390/vaccines8040713] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Dabas Y, Xess I, Pandey M, Ahmed J, Sachdev J, Iram A, Singh G, Mahapatra M, Seth R, Bakhshi S, Kumar R, Jyotsna VP, Mathur S. Epidemiology and Antifungal Susceptibility Patterns of Invasive Fungal Infections (IFIs) in India: A Prospective Observational Study. J Fungi (Basel) 2021;8:33. [PMID: 35049974 DOI: 10.3390/jof8010033] [Reference Citation Analysis]
8 Moser D, Biere K, Han B, Hoerl M, Schelling G, Choukér A, Woehrle T. COVID-19 Impairs Immune Response to Candida albicans. Front Immunol 2021;12:640644. [PMID: 33717195 DOI: 10.3389/fimmu.2021.640644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bhatt K, Agolli A, Patel MH, Garimella R, Devi M, Garcia E, Amin H, Domingue C, Guerra Del Castillo R, Sanchez-Gonzalez M. High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections. Discoveries (Craiova) 2021;9:e126. [PMID: 34036149 DOI: 10.15190/d.2021.5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
10 Heuer C, Bahnemann J, Scheper T, Segal E. Paving the Way to Overcome Antifungal Drug Resistance: Current Practices and Novel Developments for Rapid and Reliable Antifungal Susceptibility Testing. Small Methods 2021;5:e2100713. [PMID: 34927979 DOI: 10.1002/smtd.202100713] [Reference Citation Analysis]
11 Frías-De-León MG, Pinto-Almazán R, Hernández-Castro R, García-Salazar E, Meza-Meneses P, Rodríguez-Cerdeira C, Arenas R, Conde-Cuevas E, Acosta-Altamirano G, Martínez-Herrera E. Epidemiology of Systemic Mycoses in the COVID-19 Pandemic. J Fungi (Basel) 2021;7:556. [PMID: 34356935 DOI: 10.3390/jof7070556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Talento AF, Hoenigl M. Fungal Infections Complicating COVID-19: With the Rain Comes the Spores. J Fungi (Basel) 2020;6:E279. [PMID: 33187364 DOI: 10.3390/jof6040279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Borg D, Farrugia J, Mallia Azzopardi C. SARS-CoV-2 related ARDS and Invasive Fungal Infections in Intensive Care Patients. Clin Infect Pract 2021;:100127. [PMID: 34901829 DOI: 10.1016/j.clinpr.2021.100127] [Reference Citation Analysis]
14 Leistner R, Schroeter L, Adam T, Poddubnyy D, Stegemann M, Siegmund B, Maechler F, Geffers C, Schwab F, Gastmeier P, Treskatsch S, Angermair S, Schneider T. Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients. Crit Care 2022;26. [DOI: 10.1186/s13054-022-03902-8] [Reference Citation Analysis]
15 Taylor M, Ghodasara A, Ismail A, Gauhar U, El-Kersh K. Disseminated Histoplasmosis in an Immunocompetent Patient After COVID-19 Pneumonia. Cureus 2021;13:e17269. [PMID: 34540490 DOI: 10.7759/cureus.17269] [Reference Citation Analysis]
16 Hoenigl M, Levitz SM, Schuetz AN, Zhang SX, Cornely OA. All You Need to Know and More about the Diagnosis and Management of Rare Mold Infections. mBio 2021;12:e02920-20. [PMID: 33622731 DOI: 10.1128/mBio.02920-20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Apostolopoulou A, Clancy CJ, Skeel A, Nguyen MH. Invasive Pulmonary Aspergillosis Complicating Noninfluenza Respiratory Viral Infections in Solid Organ Transplant Recipients. Open Forum Infect Dis 2021;8:ofab478. [PMID: 34805426 DOI: 10.1093/ofid/ofab478] [Reference Citation Analysis]
18 García Clemente M, Madrid Carbajal C, Iscar Urrutia M. Influenza, SARS-CoV-2 and Invasive Pulmonary Aspergillosis. Arch Bronconeumol 2021;57 Suppl 1:11-2. [PMID: 33268140 DOI: 10.1016/j.arbres.2020.09.012] [Reference Citation Analysis]
19 Rokas A. Evolution of the human pathogenic lifestyle in fungi. Nat Microbiol 2022;7:607-19. [PMID: 35508719 DOI: 10.1038/s41564-022-01112-0] [Reference Citation Analysis]
20 Basile K, Halliday C, Kok J, Chen SC. Fungal Infections Other Than Invasive Aspergillosis in COVID-19 Patients. JoF 2022;8:58. [DOI: 10.3390/jof8010058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Salazar F, Bignell E, Brown GD, Cook PC, Warris A. Pathogenesis of Respiratory Viral and Fungal Coinfections. Clin Microbiol Rev 2021;:e0009421. [PMID: 34788127 DOI: 10.1128/CMR.00094-21] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
22 Monk BC, Keniya MV. Roles for Structural Biology in the Discovery of Drugs and Agrochemicals Targeting Sterol 14α-Demethylases. J Fungi (Basel) 2021;7:67. [PMID: 33498194 DOI: 10.3390/jof7020067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Jenks JD, Gangneux JP, Schwartz IS, Alastruey-Izquierdo A, Lagrou K, Thompson Iii GR, Lass-Flörl C, Hoenigl M; European Confederation of Medical Mycology (ECMM) Council Investigators. Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement. J Fungi (Basel) 2020;6:E216. [PMID: 33050598 DOI: 10.3390/jof6040216] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
24 Gioia F, Albasata H, Hosseini-moghaddam SM. Concurrent Infection with SARS-CoV-2 and Pneumocystis jirovecii in Immunocompromised and Immunocompetent Individuals. JoF 2022;8:585. [DOI: 10.3390/jof8060585] [Reference Citation Analysis]
25 Jenks JD, Prattes J, Buchheidt D, Hoenigl M. Reply to Mikulska, Furfaro, and Bassetti. Clin Infect Dis 2020:ciaa1670. [PMID: 33125456 DOI: 10.1093/cid/ciaa1670] [Reference Citation Analysis]
26 Samaddar A, Diwakar J, Krishnan P, Veena Kumari HB, Kavya M, Konar S, Sharma DA, Nandeesh BN, Goyal A, Nagarathna S. COVID-19-associated brain abscess caused by Trichosporon dohaense: A case report and review of literature. Med Mycol Case Rep 2022;35:9-14. [PMID: 34931159 DOI: 10.1016/j.mmcr.2021.12.002] [Reference Citation Analysis]
27 Zurl C, Hoenigl M, Schulz E, Hatzl S, Gorkiewicz G, Krause R, Eller P, Prattes J. Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy. J Fungi (Basel) 2021;7:88. [PMID: 33513875 DOI: 10.3390/jof7020088] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 13.0] [Reference Citation Analysis]
28 Carbone M, Lednicky J, Xiao SY, Venditti M, Bucci E. Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For. J Thorac Oncol 2021;16:546-71. [PMID: 33422679 DOI: 10.1016/j.jtho.2020.12.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
29 Samson R, Dharne M. COVID-19 associated mucormycosis: evolving technologies for early and rapid diagnosis. 3 Biotech 2022;12:6. [PMID: 34900512 DOI: 10.1007/s13205-021-03080-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Ayalon O, Cohen MJ, Orenbuch-harroch E, Sviri S, van Heerden PV, Korem M. Invasive fungal infections in critically ill COVID-19 patients in a large tertiary university hospital in Israel. Journal of Critical Care 2022;69:154004. [DOI: 10.1016/j.jcrc.2022.154004] [Reference Citation Analysis]
31 Chong WH, Neu KP. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review. J Hosp Infect 2021;113:115-29. [PMID: 33891985 DOI: 10.1016/j.jhin.2021.04.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
32 Lal PM, Arif A, Mohan A, Rackimuthu S, Hasan MM, Islam Z, Uday U, Wara UU, Shaikh MTA, Essar MY. COVID-19 associated pulmonary aspergillosis (CAPA): An added potential burden on India's pre-existing fungal superinfection. Clin Epidemiol Glob Health 2022;13:100960. [PMID: 35005301 DOI: 10.1016/j.cegh.2021.100960] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Ghazanfari M, Arastehfar A, Davoodi L, Yazdani Charati J, Moazeni M, Abastabar M, Haghani I, Mirzakhani R, Mayahi S, Fang W, Liao W, Nguyen MH, Perlin DS, Hoenigl M, Pan W, Hedayati MT. Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients. Front Med (Lausanne) 2021;8:649675. [PMID: 34195207 DOI: 10.3389/fmed.2021.649675] [Reference Citation Analysis]
34 Abdel-rashid RS, Helal DA, Alaa-eldin AA, Abdel-monem R. Polymeric versus lipid nanocapsules for miconazole nitrate enhanced topical delivery: in vitro and ex vivo evaluation. Drug Delivery 2022;29:294-304. [DOI: 10.1080/10717544.2022.2026535] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
35 Chong WH, Saha BK, Neu KP. Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis. Infection 2021. [PMID: 34570355 DOI: 10.1007/s15010-021-01701-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Prattes J, Wauters J, Giacobbe DR, Lagrou K, Hoenigl M; ECMM-CAPA Study Group. Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry. Intensive Care Med 2021. [PMID: 34269853 DOI: 10.1007/s00134-021-06471-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
37 Barberis F, Benedetti MF, de Abreu MS, Pola SJ, Posse G, Capece P, Lausi AF, Nusblat A, Cuestas ML. Invasive fusariosis in a critically ill patient with severe COVID-19 pneumonia: A case report. Med Mycol Case Rep 2022;35:5-8. [PMID: 34931158 DOI: 10.1016/j.mmcr.2021.12.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
38 Seyedjavadi SS, Bagheri P, Nasiri MJ, Razzaghi-Abyaneh M, Goudarzi M. Fungal Infection in Co-infected Patients With COVID-19: An Overview of Case Reports/Case Series and Systematic Review. Front Microbiol 2022;13:888452. [PMID: 35875562 DOI: 10.3389/fmicb.2022.888452] [Reference Citation Analysis]
39 Rubiano C, Tompkins K, Sellers SA, Bramson B, Eron J, Parr JB, Schranz AJ. Pneumocystis and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection: A Case Report and Review of an Emerging Diagnostic Dilemma. Open Forum Infect Dis 2021;8:ofaa633. [PMID: 33537365 DOI: 10.1093/ofid/ofaa633] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
40 Kula BE, Clancy CJ, Hong Nguyen M, Schwartz IS. Invasive mould disease in fatal COVID-19: a systematic review of autopsies. Lancet Microbe 2021;2:e405-14. [PMID: 34189490 DOI: 10.1016/S2666-5247(21)00091-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]